SeekGene
Beijing
About SeekGene
SeekGene is a provider of genetic data analysis solutions focused on the development and clinical transformation of single cell sorting assays. The SeekGene operations team has many years of research and clinical service experience, focusing on the application of single-cell sequencing technology in real-world clinical research. Its self-developed high-throughput single-cell transcriptome sequencing kit achieves world-leading performance, and is flexible, simple, economical, and accurate, which can accelerate the clinical transformation of single-cell sequencing technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Total funding: $15.4M
- Funding stage: Early Stage Venture
- Last round: Series B (Mar 2022)
- Website: seekgene.com
- Phone: [email protected]
Industries & Categories
Analytics, Clinical Trials, Health Care
Canonical: https://fsome.com/organization/seekgene-121217 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.